Cocrystal Pharma Inc. (COCP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cocrystal Pharma Inc.

    NASDAQ: COCP · Real-Time Price · USD
    1.47
    0.01 (0.63%)
    At close: Sep 05, 2025, 3:59 PM
    1.48
    0.68%
    After-hours: Sep 05, 2025, 07:52 PM EDT

    Cocrystal Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 126K 15.17K 241.6K 239.5K
    Gross Profit
    		 -126K -15.17M -241.6K -239.5K
    Operating Income
    		 -17.88M -21.16M -38.83M -14.22M
    Interest Income
    		 537K n/a 2.00 4.00
    Pretax Income
    		 -17.5M -17.98M -38.84M -14.19M
    Net Income
    		 -17.5M -17.98M -38.84M -14.19M
    Selling & General & Admin
    		 5.34M 5.99M 5.75M 5.43M
    Research & Development
    		 12.54M 15.17M 12.39M 8.79M
    Other Expenses
    		 n/a -2.6M 20.69M n/a
    Operating Expenses
    		 17.88M 18.56M 17.75M 14.22M
    Interest Expense
    		 n/a n/a 2K 4K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 17.88M 18.56M 18.14M 14.22M
    Income Tax Expense
    		 n/a n/a 8K 4K
    Shares Outstanding (Basic)
    		 10.17M 9.65M 8.14M 7.69M
    Shares Outstanding (Diluted)
    		 10.17M 9.65M 8.14M 7.69M
    EPS (Basic)
    		 -1.72 -0.00 -4.77 -1.85
    EPS (Diluted)
    		 -1.72 -0.00 -4.77 -1.85
    EBITDA
    		 -17.43M -19.37M -17.75M -13.8M
    EBIT
    		 -17.88M -17.98M -38.84M -14.18M
    Depreciation & Amortization
    		 446K -1.39M 388K 382K

    Add to Watchlist